Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis

Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis

Abstract Introduction Pain control is one of the most important aspects of rheumatoid arthritis (RA) management from the patient’s perspective. Newer generations of RA treatment including tumor necrosis factor inhibitor (TNFi) have the potential to alleviate pain and thus reduce opioid utilization....

Full description

Bibliographic Details
Main Authors: Siyeon Park, Tham T. Le, Julia F. Slejko, Ester Villalonga-Olives, Eberechukwu Onukwugha
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-10-01
Series:Rheumatology and Therapy
Subjects:
Biologic treatment
Claims database
Opioid
Rheumatoid arthritis
Tumor necrosis factor inhibitors
Online Access:http://link.springer.com/article/10.1007/s40744-019-00175-6

Internet

http://link.springer.com/article/10.1007/s40744-019-00175-6

Similar Items